Institutional appetite for cryptocurrency exposure continues to strengthen. According to the latest weekly report from CoinShares, digital asset investment products saw a substantial $864 million in net inflows last week. This marks the third consecutive week of positive momentum, signaling a sustained recovery in investor sentiment.Institutional appetite for cryptocurrency exposure continues to strengthen. According to the latest weekly report from CoinShares, digital asset investment products saw a substantial $864 million in net inflows last week. This marks the third consecutive week of positive momentum, signaling a sustained recovery in investor sentiment.

Digital Asset Inflows Surge to $864M, Marking Third Consecutive Week of Growth

2025/12/15 20:45
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Meta Description: Institutional confidence in crypto returns as digital asset investment products record $864 million in inflows for a third straight week, according to the latest data from CoinShares.

Keywords: CoinShares, Digital Asset Inflows, Crypto Investment, Bitcoin, Ethereum, Institutional Investors, Market Trends

The Lead
Institutional appetite for cryptocurrency exposure continues to strengthen. According to the latest weekly report from CoinShares, digital asset investment products saw a substantial $864 million in net inflows last week. This marks the third consecutive week of positive momentum, signaling a sustained recovery in investor sentiment.

Key Drivers of Growth
The consistent inflows suggest that investors are looking past short-term volatility and positioning themselves for potential future gains. Several factors are likely contributing to this trend:

  • Renewed Optimism: The steady accumulation of assets indicates that fund managers and institutional players are becoming increasingly bullish on the sector's outlook.
  • Bitcoin Dominance: Historically, Bitcoin products tend to capture the lion's share of these inflows, acting as the primary vehicle for institutional capital entering the market.
  • Regulatory Clarity Hopes: With shifting political landscapes (as noted in recent SEC enforcement news), investors may be anticipating a more favorable regulatory environment, encouraging capital deployment.

Market Implications
Three weeks of consecutive inflows totaling hundreds of millions of dollars provides a strong foundation for price stability. When investment products—such as ETFs and ETPs—absorb supply, it can alleviate selling pressure on the spot market. This data point from CoinShares serves as a critical lagging indicator of institutional sentiment, confirming that "smart money" is currently in accumulation mode.

Conclusion
While the crypto market is known for its rapid shifts, a three-week streak of inflows approaching the billion-dollar mark is a significant metric. It demonstrates that despite broader macroeconomic uncertainties, the investment thesis for digital assets remains robust among professional allocators.

Market Opportunity
SURGE Logo
SURGE Price(SURGE)
$0.01854
$0.01854$0.01854
-9.02%
USD
SURGE (SURGE) Live Price Chart
Disclaimer: The articles published on this page are written by independent contributors and do not necessarily reflect the official views of MEXC. All content is intended for informational and educational purposes only and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC. Cryptocurrency markets are highly volatile — please conduct your own research and consult a licensed financial advisor before making any investment decisions.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09